Cargando…
Proteomics technologies for cancer liquid biopsies
Alterations in DNAs could not reveal what happened in proteins. The accumulated alterations of DNAs would change the manifestation of proteins. Therefore, as is the case in cancer liquid biopsies, deep proteome profiling will likely provide invaluable and clinically relevant information in real-time...
Autores principales: | Ding, Zhiyong, Wang, Nan, Ji, Ning, Chen, Zhe-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845389/ https://www.ncbi.nlm.nih.gov/pubmed/35168611 http://dx.doi.org/10.1186/s12943-022-01526-8 |
Ejemplares similares
-
The Use of Microfluidic Technology for Cancer Applications and Liquid Biopsy
por: Kulasinghe, Arutha, et al.
Publicado: (2018) -
Advances in Liquid Biopsy Technology and Implications for Pancreatic Cancer
por: Raufi, Alexander G., et al.
Publicado: (2023) -
Liquid biopsy: current technology and clinical applications
por: Nikanjam, Mina, et al.
Publicado: (2022) -
Challenges and achievements of liquid biopsy technologies employed in early breast cancer
por: Alba-Bernal, Alfonso, et al.
Publicado: (2020) -
Perspectives of the Application of Liquid Biopsy in Colorectal Cancer
por: Ding, Yuhan, et al.
Publicado: (2020)